Antiaging Quantum Living Inc.

Earnings Score

Market Cap $31.79M
Debt $431.36K
Cash $37.40K
EV $32.19M
FCF $NaN

Earnings

loading chart...

Sales & Net Margins

loading chart...

Earnings	-$770.52K
EBIT	-$770.52K
ROA	-97%
Equity	-$841.70K
Growth Stability	-4K%
PE	-41.26
PB	-37.77
P/S	83.33
Price/Cash	0
Debt/Equity	-0.51
Net Margins	-110%
Gross Margins	96%
Op. Margins	-202%
Earnings CAGR	0%
Sales Growth QoQ	-14%
Sales CAGR	8%
Equity CAGR	1%
Earnings Stability	-0.24
Earnings Growth YoY	711%
Earnings Growth QoQ	-8%

Sales CAGR 5Y	96%
Equity CAGR 5Y	-3%
Earnings CAGR 3Y	165%
Sales CAGR 3Y	165%
Market Cap	$31.79M
Revenue	$381.54K
Assets	$797.25K
Total Debt	$431.36K
Cash	$37.40K
Shares Outstanding	30M
EV	32.19M
Earnings Score	6%
Working Capital	-986.43K
Current Ratio	0.15
Gross Profit	$366.23K
Shares Growth 3y	-0%
Equity Growth QoQ	35%
Equity Growth YoY	1K%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...

Premier Anti-Aging Co., Ltd. engages in the planning, development, import, export, mail order, wholesale, and retail business of cosmetics and health foods in Japan. It offers its cosmetic products under the DUO, CANADEL, Immuno, Sitrana, and Clayence brands. The company was incorporated in 2009 and is headquartered in Tokyo, Japan.

SEC Filings

Direct access to Antiaging Quantum Living Inc. (AAQL) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

2024
- 10-Q Sep 30
- 10-Q Jun 30
- 10-K Mar 31
2023
- 10-Q Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-K Mar 31
2022
- 10-Q Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-K Mar 31

Sector Comparison

How does Antiaging Quantum Living Inc. compare to its competitors?

Not enough data to generate a comparison chart between Antiaging Quantum Living Inc. and its competitors. Please check back later.

Peter Lynch's Chart

This chart shows the current pricing of Antiaging Quantum Living Inc. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR 0%

Stability -24%

loading chart...

Antiaging Quantum Living Inc. Discounted Cash Flow

Fully customizable DCF calculator online for Antiaging Quantum Living Inc..

Years

Calculation mode

	0	1	2	3	4	5	6	7	8	9	10	TV
fcf	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
DCF		$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Value	$0

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years	03/2017	03/2018	03/2019	03/2020	03/2021	03/2022	03/2023	03/2024	TTM
Net Margins	-	-	-	-	-2K%	-587%	-269%	-6K%	-110%
ROA	-	6%	9%	-45%	-97%	-287%	-4K%	-41%	-97%
ROE	-	7%	8%	-98%	1K%	88%	43%	100%	-

Bad Net Margins (-109.7%)

Net Margins are too low to guarantee profitability in case of higher costs or higher interest rates. Furthermore lower margins cause higher earnings’ volatility.

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years	03/2017	03/2018	03/2019	03/2020	03/2021	03/2022	03/2023	03/2024	TTM
Debt over FCF	-	-	-	-	-	-	-	-	-
Debt over Equity	-	-	-	-	-	-	-	-1.01	-0.51
Growth Stability	-	-	-	-4K%	-	-	-	-	-4K%

Neutral Debt/FCF ratio (-)

Net Margins are at a level that is not too high nor too low. They are not a competitive advantage but they are not a competitive disadvantage either.

Good Debt/Equity ratio (-0.51)

The company is not overleveraged and has a good balance between equity and debt.

Bad Graham’s Stability (-4K%)

The company has a bad stability in its earnings, which is a sign of a bad competitive advantage.

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years	03/2017	03/2018	03/2019	03/2020	03/2021	03/2022	03/2023	03/2024	CAGR 5Y
Revenue YoY growth	-	-	-	-	-	95%	84%	-45%	96%
Earnings YoY growth	-	-225%	170%	-2K%	13%	-35%	-16%	1K%	-
Equity YoY growth	-	1K%	123%	14%	-110%	719%	74%	380%	-3%
FCF YoY growth	-	-	-	-	-	-	-	-	-